VXRT
Closed
Vaxart Inc
0.6196
+0.0163 (+2.70%)
Last Update: 21 Dec 2024 00:18:00
Yesterday: 0.6033
Day's Range: 0.59 - 0.6399
Send
sign up or login to leave a comment!
When Written:
0.6089
Vaxart Inc. is a clinical-stage biotechnology company that develops oral vaccines to prevent infectious diseases. The company's proprietary oral vaccine platform uses a recombinant adenovirus technology to deliver vaccine antigens to the immune system. Vaxart's vaccines are designed to provide broad protection against multiple strains of a virus, including emerging variants.
The company's lead product candidate is an oral tablet vaccine for COVID-19, which is currently in Phase II clinical trials. Vaxart also has vaccine candidates in development for influenza, norovirus, and respiratory syncytial virus (RSV).
Vaxart was founded in 2004 and is headquartered in South San Francisco, California. The company went public in 2019 and is traded on the NASDAQ under the ticker symbol VXRT.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company's lead product candidate is an oral tablet vaccine for COVID-19, which is currently in Phase II clinical trials. Vaxart also has vaccine candidates in development for influenza, norovirus, and respiratory syncytial virus (RSV).
Vaxart was founded in 2004 and is headquartered in South San Francisco, California. The company went public in 2019 and is traded on the NASDAQ under the ticker symbol VXRT.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!